Sonoma Pharmaceuticals (SNOA) Operating Expenses (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Operating Expenses of $2.5 million for Q1 2026, up 15.93% year-over-year from $2.2 million in Q1 2025, and up 8.76% quarter-over-quarter from $2.3 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Operating Expenses (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Operating Expenses history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 15.93% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $9.9 million (up 7.64% YoY), while the FY2026 annual figure was $9.9 million, up 7.64% from the prior year.
- Operating Expenses for Q1 2026 stood at $2.5 million, up from $2.3 million in the prior quarter.
- The five-year high for Operating Expenses was $3.2 million in Q1 2022, with the low at $2.0 million in Q1 2023.
- The 5-year median for Operating Expenses is $2.4 million (2023), against an average of $2.4 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 36.28% in 2023, then advanced 24.32% in 2024.
- Sonoma Pharmaceuticals' Operating Expenses stood at $2.7 million in 2022, then declined by 13.55% to $2.3 million in 2023, then dropped by 0.13% to $2.3 million in 2024, then grew by 1.17% to $2.3 million in 2025, then rose by 8.76% to $2.5 million in 2026.
- Business Quant data shows SNOA's Operating Expenses at $2.5 million in Q1 2026, $2.3 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.19 Mn | -145,899.91 | 2.58 Mn | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.62 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.56 Mn |
| Mar 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 2.44 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 3.16 Mn |
| Dec 31, 2021 | 2.16 Mn |
| Sep 30, 2021 | 2.21 Mn |